{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:34:14Z","timestamp":1772678054739,"version":"3.50.1"},"reference-count":48,"publisher":"China Science Publishing & Media Ltd.","issue":"4","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":270,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["direct.mit.edu"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,25]]},"abstract":"<jats:p>The findable, accessible, interoperable, reusable (FAIR) principles for scientific data management and stewardship aim to facilitate data reuse at scale by both humans and machines. Research and development (R&amp;D) in the pharmaceutical industry is becoming increasingly data driven, but managing its data assets according to FAIR principles remains costly and challenging. To date, little scientific evidence exists about how FAIR is currently implemented in practice, what its associated costs and benefits are, and how decisions are made about the retrospective FAIRification of data sets in pharmaceutical R&amp;D. This paper reports the results of semi-structured interviews with 14 pharmaceutical professionals who participate in various stages of drug R&amp;D in seven pharmaceutical businesses. Inductive thematic analysis identified three primary themes of the benefits and costs of FAIRification, and the elements that influence the decision-making process for FAIRifying legacy data sets. Participants collectively acknowledged the potential contribution of FAIRification to data reusability in diverse research domains and the subsequent potential for cost-savings. Implementation costs, however, were still considered a barrier by participants, with the need for considerable expenditure in terms of resources, and cultural change. How decisions were made about FAIRification was influenced by legal and ethical considerations, management commitment, and data prioritisation. The findings have significant implications for those in the pharmaceutical R&amp;D industry who are engaged in driving FAIR implementation, and for external parties who seek to better understand existing practices and challenges.<\/jats:p>","DOI":"10.1162\/dint_a_00109","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T21:29:48Z","timestamp":1632864588000},"page":"507-527","update-policy":"https:\/\/doi.org\/10.1162\/mitpressjournals.corrections.policy","source":"Crossref","is-referenced-by-count":19,"title":["Exploring the Current Practices, Costs and Benefits of FAIR Implementation in Pharmaceutical Research and Development: A Qualitative Interview Study"],"prefix":"10.3724","volume":"3","author":[{"given":"Ebtisam","family":"Alharbi","sequence":"first","affiliation":[{"name":"School of Computer Science, University of Manchester, Manchester, Manchester M13 9PL, UK"},{"name":"College of Computer and Information Systems, Umm Al-Qura University, Mecca, Makkah 21421, Saudi Arabia"}]},{"given":"Rigina","family":"Skeva","sequence":"additional","affiliation":[{"name":"School of Computer Science, University of Manchester, Manchester, Manchester M13 9PL, UK"}]},{"given":"Nick","family":"Juty","sequence":"additional","affiliation":[{"name":"School of Computer Science, University of Manchester, Manchester, Manchester M13 9PL, UK"}]},{"given":"Caroline","family":"Jay","sequence":"additional","affiliation":[{"name":"School of Computer Science, University of Manchester, Manchester, Manchester M13 9PL, UK"}]},{"given":"Carole","family":"Goble","sequence":"additional","affiliation":[{"name":"School of Computer Science, University of Manchester, Manchester, Manchester M13 9PL, UK"}]}],"member":"2026","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"2021102516595639600_ref1","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2016.18","article-title":"The FAIR guiding principles for scientific data management and stewardship","volume":"3","author":"Wilkinson","year":"2016","journal-title":"Scientific Data"},{"issue":"1","key":"2021102516595639600_ref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/ISU-170824","article-title":"Cloudy, increasingly FAIR; revisiting the FAIR data guiding principles for the European Open Science Cloud","volume":"37","author":"Mons","year":"2017","journal-title":"Information Services & Use"},{"key":"2021102516595639600_ref3","volume-title":"Turning FAIR into reality","author":"European Commission","year":"2021"},{"issue":"1\u20132","key":"2021102516595639600_ref4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1162\/dint_a_00039","article-title":"The FAIR funding model: Providing a framework for research funders to drive the transition toward FAIR data management and stewardship practices","volume":"2","author":"Bloemers","year":"2020","journal-title":"Data Intelligence"},{"issue":"4","key":"2021102516595639600_ref5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/ISU-200102","article-title":"An academic publishers' GO FAIR implementation network (APIN)","volume":"40","author":"Velterop","year":"2020","journal-title":"Information Services & Use"},{"issue":"1\u20132","key":"2021102516595639600_ref6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1162\/dint_r_00024","article-title":"FAIR principles: Interpretations and implementation considerations","volume":"2","author":"Jacobsen","year":"2020","journal-title":"Data Intelligence"},{"key":"2021102516595639600_ref7","volume-title":"Data stewardship for open science: Implementing FAIR principles","author":"Mons","year":"2020","edition":"1st edition"},{"key":"2021102516595639600_ref8","volume-title":"Cost-benefit analysis for FAIR research data\u2014Cost of not having FAIR research data (2019)","author":"European Commission"},{"key":"2021102516595639600_ref9","volume-title":"Realising the European Open Science Cloud (2016)","author":"European Commission"},{"key":"2021102516595639600_ref10","volume-title":"Expert Group on Open Science","author":"G7","year":"2017"},{"key":"2021102516595639600_ref11","volume-title":"GO FAIR"},{"issue":"4","key":"2021102516595639600_ref12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.drudis.2019.01.008","article-title":"Implementation and relevance of FAIR data principles in biopharmaceutical R&D","volume":"24","author":"Wise","year":"2019","journal-title":"Drug Discovery Today"},{"issue":"1\u20132","key":"2021102516595639600_ref13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1162\/dint_a_00050","article-title":"The need of industry to go FAIR","volume":"2","author":"van Vlijmen","year":"2020","journal-title":"Data Intelligence"},{"issue":"2","key":"2021102516595639600_ref14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/bio.2017.0110","article-title":"Enhancing reuse of data and biological material in medical research: From FAIR to FAIR-health","volume":"16","author":"Holub","year":"2018","journal-title":"Biopreservation and Biobanking"},{"key":"2021102516595639600_ref15","volume-title":"The R&D cost of a new medicine (2012)","author":"Mestre-Ferrandiz"},{"issue":"3","key":"2021102516595639600_ref16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"2021102516595639600_ref17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.drudis.2018.01.034","article-title":"The positive impacts of real-world data on the challenges facing the evolution of biopharma","volume":"23","author":"Wise","year":"2018","journal-title":"Drug Discovery Today"},{"issue":"7","key":"2021102516595639600_ref18","doi-asserted-by":"crossref","first-page":"e201303017","DOI":"10.5936\/csbj.201303017","article-title":"The innovative medicines initiative: A public private partnership model to foster drug discovery","volume":"6","author":"Vaudano","year":"2013","journal-title":"Computational and Structural Biotechnology Journal"},{"issue":"5","key":"2021102516595639600_ref19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08956308.2017.1348135","article-title":"Big data and the future of R&D management: The rise of big data and big data analytics will have significant implications for R&D and innovation management in the next decade","volume":"60","author":"Blackburn","year":"2017","journal-title":"Research-Technology Management"},{"issue":"2","key":"2021102516595639600_ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40290-015-0090-x","article-title":"Big data in pharmaceutical R&D: Creating a sustainable R&D engine","volume":"29","author":"Tormay","year":"2015","journal-title":"Pharmaceutical Medicine"},{"key":"2021102516595639600_ref21","volume-title":"The Pistoia Alliance FAIR Toolkit"},{"key":"2021102516595639600_ref22","volume-title":"The IMI FAIRplus FAIR Cookbook"},{"key":"2021102516595639600_ref23","doi-asserted-by":"crossref","DOI":"10.1162\/99608f92.a010feeb","volume-title":"How to define and execute your data and AI strategy","author":"Kruhse-Lehtonen","year":"2020"},{"issue":"5","key":"2021102516595639600_ref24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.drudis.2021.01.017","article-title":"Best practices for artificial intelligence in life sciences research","volume":"26","author":"Makarov","year":"2021","journal-title":"Drug Discovery Today"},{"issue":"7706","key":"2021102516595639600_ref25","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/d41586-018-05267-x","article-title":"How artificial intelligence is changing drug discovery","volume":"557","author":"Fleming","year":"2018","journal-title":"Nature"},{"issue":"6","key":"2021102516595639600_ref26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nature Reviews Drug Discovery"},{"key":"2021102516595639600_ref27","volume-title":"Overcoming the challenges to making data FAIR in pharma (2020)","author":"Slate"},{"issue":"1\u20132","key":"2021102516595639600_ref28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1162\/dint_a_00028","article-title":"A generic workflow for the data FAIRification process","volume":"2","author":"Jacobsen","year":"2020","journal-title":"Data Intelligence"},{"key":"2021102516595639600_ref29","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-019-0286-0","article-title":"Experiment design driven FAIRification of omics data matrices, an exemplar","volume":"6","author":"Rocca-Serra","year":"2019","journal-title":"Scientific Data"},{"key":"2021102516595639600_ref30","volume-title":"Driving FAIR in biopharma report (2021)","author":"Genomics"},{"key":"2021102516595639600_ref31","volume-title":"Transforming R&D with data report (2020)","author":"Front Line Genomics"},{"key":"2021102516595639600_ref32","doi-asserted-by":"crossref","DOI":"10.1002\/0470013192.bsa514","article-title":"Qualitative research","volume-title":"The Encyclopedia of Statistics in Behavioral Science","author":"Patton","year":"2005"},{"key":"2021102516595639600_ref33","volume-title":"Qualitative research","author":"Silverman","year":"2020"},{"issue":"4","key":"2021102516595639600_ref34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2929.2006.02418.x","article-title":"The qualitative research interview","volume":"40","author":"DiCicco-Bloom","year":"2006","journal-title":"Medical Education"},{"key":"2021102516595639600_ref35","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-020-0524-5","article-title":"COVID-19 pandemic reveals the peril of ignoring metadata standards","volume":"7","author":"Schriml","year":"2020","journal-title":"Scientific Data"},{"issue":"6","key":"2021102516595639600_ref36","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41431-020-0635-7","article-title":"The VODAN IN: Support of a FAIR-based infrastructure for COVID-19","volume":"28","author":"Mons","year":"2020","journal-title":"European Journal of Human Genetics"},{"key":"2021102516595639600_ref37","volume-title":"RDA COVID19 case statement (2020)","author":"Research Data Alliance (RDA) COVID 19 Working Group"},{"issue":"3","key":"2021102516595639600_ref38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpt.318","article-title":"Leveraging big data to transform target selection and drug discovery","volume":"99","author":"Chen","year":"2016","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"8","key":"2021102516595639600_ref39","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine learning in chemoinformatics and drug discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug Discovery Today"},{"issue":"1","key":"2021102516595639600_ref40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.pmch.2017.12.003","article-title":"Big data in drug discovery","volume":"57","author":"Brown","year":"2018","journal-title":"Progress in Medicinal Chemistry"},{"key":"2021102516595639600_ref41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/d41586-019-01720-7","article-title":"Make scientific data FAIR","volume":"570","author":"Stall","year":"2019","journal-title":"Nature"},{"issue":"8","key":"2021102516595639600_ref42","doi-asserted-by":"crossref","first-page":"e0134826","DOI":"10.1371\/journal.pone.0134826","article-title":"Changes in data sharing and data reuse practices and perceptions among scientists worldwide","volume":"10","author":"Tenopir","year":"2015","journal-title":"PLoS ONE"},{"key":"2021102516595639600_ref43","doi-asserted-by":"crossref","DOI":"10.1101\/581033","volume-title":"Knowledge and attitudes among life scientists towards reproducibility within journal articles","author":"Samota","year":"2019"},{"issue":"2","key":"2021102516595639600_ref44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lisr.2019.04.004","article-title":"Global perspectives of research data sharing: A systematic literature review","volume":"41","author":"Chawinga","year":"2019","journal-title":"Library & Information Science Research"},{"key":"2021102516595639600_ref45","volume-title":"Data sharing and reuse in interdisciplinary scientific collaborations: Challenges of heterogeneous practice (2018)","author":"Borgman"},{"issue":"7","key":"2021102516595639600_ref46","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41431-018-0160-0","article-title":"The FAIR guiding principles for data stewardship: Fair enough?","volume":"26","author":"Boeckhout","year":"2018","journal-title":"European Journal of Human Genetics"},{"issue":"8","key":"2021102516595639600_ref47","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/jama.2015.292","article-title":"Sharing clinical trial data: Maximizing benefits, minimizing risk","volume":"313","author":"Lo","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"2021102516595639600_ref48","doi-asserted-by":"crossref","first-page":"e1005873","DOI":"10.1371\/journal.pcbi.1005873","article-title":"A FAIR guide for data providers to maximise sharing of human genomic data","volume":"14","author":"Corpas","year":"2018","journal-title":"PLoS Computational Biology"}],"container-title":["Data Intelligence"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/direct.mit.edu\/dint\/article-pdf\/3\/4\/507\/1968563\/dint_a_00109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/direct.mit.edu\/dint\/article-pdf\/3\/4\/507\/1968563\/dint_a_00109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T07:44:21Z","timestamp":1741938261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.1162\/dint_a_00109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10,25]]}},"URL":"https:\/\/doi.org\/10.1162\/dint_a_00109","relation":{},"ISSN":["2641-435X"],"issn-type":[{"value":"2641-435X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021]]},"published":{"date-parts":[[2021]]}}}